Triumvira Immunologics Jobs and Company Culture | Powderkeg
2022 Top Rated Biotech
Triumvira Immunologics logo

Triumvira Immunologics

Triumvira Immunologics, Inc. (“Triumvira”) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the vision of developing novel T cell therapies that are safer and more efficacious than current cancer treatments, including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. Their proprietary T cell Antigen Coupler (TAC) technology recruits the entire natural T cell receptor and is independent of the major histocompatibility complex (MHC), allowing for the development of better therapies for a broader range of patients with solid or liquid malignancies and also with diseases other than cancer.

BioTech
Austin, TX
$25M-100M

Funding

11-50

Employees

Company Mission

At Triumvira, our team is dedicated to finding a cure and providing new hope for patients with a life-threatening disease.

Is Triumvira Immunologics the next step in your tech career? Find out now.

Looking for a better job?

Discover the best career opportunities with the best company cultures for you.

Do you work at this company?

Connect your business to thousands of engaged professionals in your city and beyond.